During the last session, ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s traded shares were 5.49 million, with the beta value of the company hitting 0.68. At the end of the trading day, the stock’s price was $0.66, reflecting an intraday gain of 15.45% or $0.09. The 52-week high for the ZVSA share is $6.30, that puts it down -854.55 from that peak though still a striking 28.79% gain since the share price plummeted to a 52-week low of $0.47. The company’s market capitalization is $3.14M, and the average intraday trading volume over the past 10 days was 0.9 million shares, and the average trade volume was 3.64 million shares over the past three months.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
ZyVersa Therapeutics Inc (ZVSA) registered a 15.45% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 15.45% in intraday trading to $0.66, hitting a weekly high. The stock’s 5-day price performance is 19.80%, and it has moved by -1.72% in 30 days. Based on these gigs, the overall price performance for the year is -84.71%. The short interest in ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 0.36 million shares and it means that shorts have 0.06 day(s) to cover.
ZVSA Dividends
ZyVersa Therapeutics Inc is due to release its next quarterly earnings on 2024-Nov-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
ZyVersa Therapeutics Inc insiders own 0.17% of total outstanding shares while institutional holders control 1.06%, with the float percentage being 1.06%.
Also, the Mutual Funds coming in first place with the largest holdings of ZyVersa Therapeutics Inc (ZVSA) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 18.08 shares. This amounts to just over 0.38 percent of the company’s overall shares, with a $11912.0 market value. The same data shows that the other fund manager holds slightly less at 3.63, or about 0.08% of the stock, which is worth about $2389.0.
